Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Novel acylation-first route for Ioxilan reduces impurities and enhances scalability for contrast agent manufacturing.
Patent CN102154384A reveals efficient recombinant E. coli method yielding >26g/L with >99% ee, offering significant cost and supply chain advantages.
Patent CN104846025A details enzymatic synthesis of chiral intermediates. Offers cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN105646618B reveals tin-catalyzed reduction amination for Gamithromycin. Offers safer conditions and reduced boron waste for supply chain efficiency.
Patent CN107162987A reveals a high-purity rilpivirine intermediate synthesis. Offers cost reduction and supply chain reliability for pharmaceutical manufacturing partners.
Novel low-temperature demethylation process ensures high purity desmethylvenlafaxine intermediate with significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel Boc-protection route for Tulathromycin avoids Pd/C hydrogenation. Enhances supply chain reliability and reduces safety hazards in veterinary antibiotic manufacturing.
Patent CN107162987A offers high-purity rilpivirine intermediate synthesis. Reduces toxic reagents, improves yield, ensures supply chain stability for API manufacturers.
Patent CN108299445B reveals a catalyst-free thermal synthesis of 1,5-azaspiro[2,4]heptane. This method offers high purity, cis-selectivity, and reduced manufacturing costs for pharma intermediates.
Patent CN115572317A reveals a novel esterification route for Molnupiravir intermediates, offering superior purity and scalable manufacturing for global supply chains.
Patent CN102887876A reveals a high-yield route using tribromoacetaldehyde. Enhances purity and reduces costs for pharmaceutical manufacturing.
Advanced synthesis of Cefazedone Sodium via mixed anhydride method. Offers high purity, reduced costs, and scalable antibiotic manufacturing solutions.
Patent CN103951568A details new Salbutamol route offering purity and supply chain advantages for pharmaceutical intermediates manufacturing globally.
Patent CN108997362B reveals a cost-effective one-pot synthesis for pyranoindolone fused medium-rings, eliminating precious metals for reliable pharmaceutical intermediate supply.
Patent CN107858384A reveals a fusion enzyme method for L-tert-leucine. Offers high purity, thermal stability, and reusable biocatalysts for cost-effective pharmaceutical intermediate manufacturing.
Patent CN107556355B discloses a novel synthesis route for high-purity nucleoside diphosphite amides, enabling superior quality control in antisense drug manufacturing.
Patent CN106632312A details high-yield synthesis of Apixaban impurity standards for QC. Enables cost reduction in pharmaceutical intermediate manufacturing.
Discover the patented purification method for 2-chloro-N-(2-chloro-4-methylpyridin-3-yl) nicotinamide. Achieve >99.9% purity with scalable, cost-effective crystallization.
Patent CN113845417A details a safer continuous flow method for naproxen intermediates. Discover cost reduction and high-purity manufacturing advantages.
Novel azeotropic dehydration method reduces Impurity A below strict limits ensuring supply chain reliability for gastric acid inhibitor manufacturing processes globally